Japanese patent granted for LAG525 antibody
Filed with ASX · · 2 pages · English
Story so far
Earlier from Immutep
- Immutep granted European patent for IMP321 in cancer
- Appendix 4E & 2019 Full Year Statutory Accounts
- Entitlement Offer Results & Shortfall Notification
- Immutep Entitlement Offer Booklet
- Immutep completes recruitment of AIPAC trial in MBC
Later from Immutep
- Immutep to receive GBP4M Milestone Payment from GSK
- Immutep expands Part A of TACTI-002 due to positive data
- Immutep receives A$2.5M R&D French Tax Incentive
- Immutep presents positive TACTI-mel melanoma trial data
- Appendix 4C - quarterly
Follow Immutep into a list and get an email when it puts out news.
Follow Immutep